Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

Market Report, "OncoSec Medical Inc. (ONCS) - Product Pipeline Analysis, 2013 Update", published


Print article Print article
2014-01-16 19:31:07 - Fast Market Research recommends "OncoSec Medical Inc. (ONCS) - Product Pipeline Analysis, 2013 Update" from GlobalData, now available

OncoSec Medical Inc. (OncoSec) is a biotechnology service provider. The company provides treatments for skin cancer. Its treatments include Immunepulse and Neopulse. OncoSec's Immunepulse uses body's immune system to target local and metastasized cancer cells. Immunepulse also utilizes OMS system to deliver DNA IL-12 into the electroporated cells. The company's Neopulse uses the OMS system to destroy cancer cells. Its technology platform is based on electroporation that is a process, which opens temporary pores in the cell membrane of infected cells. It offers treatment for fatal skin cancers such as melanoma, Merkel cell lymphoma and cutaneous T-cell lymphoma. OncoSec is headquartered in San Diego, California, the US.

Full Report Details at
- www.fastmr.com/prod/761325_oncosec_medical_inc_oncs_product_pipe ..

This report is a source for data, analysis

and actionable intelligence on the OncoSec Medical Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

* Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. * Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase. * Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date. * Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application. * Data on relevant clinical trials and product patent details, wherever applicable. * Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Get this Report

* Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally. * Design and develop your product development, marketing and sales strategies. * Exploit M&A opportunities by identifying market players with the most innovative pipeline. * Develop market-entry and market expansion strategies. * Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return. * Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. * Develop competition strategies by identifying the status and likely launch of your competitors' pipeline products through review of the clinical trials, stage and phase of development, etc. * Which are the next high-value products that your competitor would add in its portfolio? - identify, understand and capitalize.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Key Facts
OncoSec Medical Inc. - Major Products and Services
OncoSec Medical Inc. Pipeline Products by Equipment Type
OncoSec Medical Inc. Pipeline Products by Development Stage
OncoSec Medical Inc. Pipeline Products by Therapy Area
OncoSec Medical Inc. Pipeline Products by Trial Phase
OncoSec Medical Inc. Pipeline Products by Milestone Summary
NeoPulse - Head And Neck Cancer
NeoPulse - Head And Neck Cancer Product Status
NeoPulse - Head And Neck Cancer Product Description
NeoPulse - Skin Cancer
NeoPulse - Skin Cancer Product Status
NeoPulse - Skin Cancer Product Description
OMS-I100 - Metastatic Melanoma
OMS-I100 - Metastatic Melanoma Product Status
OMS-I100 - Metastatic Melanoma Product Description
OMS-I100 - Metastatic Melanoma Product Milestone
OMS-I100 - Metastatic Melanoma Clinical Trial
OMS-I110 - Merkel Cell Carcinoma
OMS-I110 - Merkel Cell Carcinoma Product Status
OMS-I110 - Merkel Cell Carcinoma Product Description
OMS-I120 - Cutaneous T-Cell Lymphoma
OMS-I120 - Cutaneous T-Cell Lymphoma Product Status
OMS-I120 - Cutaneous T-Cell Lymphoma Product Description
OncoSec Medical System
OncoSec Medical System Product Status
OncoSec Medical System Product Description
OncoSec Medical System Product Milestone
OncoSec Medical System Clinical Trial
OncoSec Medical Inc. - Key Competitors
OncoSec Medical Inc. - Key Employees
OncoSec Medical Inc. - Key Employee Biographies
OncoSec Medical Inc. - Locations And Subsidiaries
Head Office
Recent Developments
OncoSec Medical Inc., Recent Developments
Dec 12, 2013: OncoSec Medical Announces Hire of Chief Medical Officer
Nov 26, 2013: OncoSec Medical to Present at the 6th Annual LD Micro Conference
Oct 04, 2013: OncoSec CEO Punit Dhillon to Present at INTERFACE 2013 Digital Health Summit
Oct 03, 2013: OncoSec Medical to Present at the 12th Annual BIO Investor Forum
Oct 01, 2013: OncoSec Medical to Present at the Cancer Vaccines and Gene Therapy Meeting
Sep 24, 2013: OncoSec Announces Melanoma Development Strategy
Sep 20, 2013: OncoSec Medical to Present at the 2013 Aegis Capital Healthcare Conference
Sep 04, 2013: OncoSec Medical to Present at the 15th Annual Rodman & Renshaw Global Investment Conference

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=761325&dt=t

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com